ArticleBMJ open ophthalmology2022

Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context.

Diana V Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.